Prof. Gabriel Panayi
Prof. Panayi, ScD, MD, FRCP was Emeritus Professor of Rheumatology at the School of Medicine King’s College London, and honorary consultant Rheumatologist to Guy’s and St. Thomas’ hospitals. He is past President of the British Society of Rheumatology. He has received numerous awards including Heberden Orator of the BSR, Master of Rheumatology of the ACR and Meritorious Service to Rheumatology from EULAR. His interest is the genetics, pathogenesis and immunotherapy of rheumatoid arthritis in which he has published over 250 papers.
Dr. Nicola Hanania
Dr. Nicola (Nick) A. Hanania, is an Associate Professor of Medicine in the Department of Medicine, Section of Pulmonary and Critical Care Medicine and Director of the Asthma Clinical Research Center at the Baylor College of Medicine in Houston, Texas. He is also Director of the Asthma Adult Clinic and Pulmonary Diagnostic services at Ben Taub General Hospital in Houston. Dr. Hanania obtained his medical degree from the University of Jordan. He completed his residency in Internal Medicine and a fellowship training at the University of Toronto, Canada. He then completed a fellowship in Critical Care Medicine at Baylor College of Medicine where he also received his Master degree in Clinical Investigations. He is board certified in internal medicine, pulmonary medicine and critical care medicine. Dr. Hanania is a fellow of the American College of Chest Physicians (ACCP), the American College of Physicians and the Royal College of Physicians and Surgeons of Canada.
Dr. Renyold Panettieri
Dr. Reynold Panettieri Jr., M. D., University of Pennsylvania Medical Center Pulmonary, Allergy & Critical Care Division, Director, Airways Biology Initiative, Adjunct Professor, Wistar Institute: Dr. Panettieri directs the Airways Biology Initiative at the University of Pennsylvania. His interests are in the cellular and molecular mechanisms that regulate airway smooth muscle cell growth and the immunobiology of airway smooth muscle. Consequences of increases in airway smooth muscle growth promote the development of irreversible airflow obstruction and airway remodeling seen in subjects with chronic severe asthma. Dr. Panettieri’s lab also focuses on cytosolic signaling pathways that mediate gene expression and alter myocyte function. In parallel with his basic science interests, Dr. Panettieri currently directs the comprehensive clinical program for the care of patients with asthma and is actively involved in clinical investigations focused on the management of asthma and COPD. In addition to his research and clinical interests, Dr. Panettieri served as chairperson of the Lung Cellular, Molecular, and Immunobiology Study Section of NIH and is a member of the American Society for Clinical Investigation
Dr. William Busse
Dr. William W. Busse is a Professor of Medicine and Head of the Allergy and Clinical Immunology Department at the University of Wisconsin Medical School in Madison, Wisconsin. He is Director of the National Institutes of Health sponsored General Clinical Research Center of the University of Wisconsin Medical School. His research interests center on the cellular and molecular mechanisms of asthma and the mechanisms of virus-induced asthma. Dr. Busse is a past President of the conjoint American Board of Allergy and Immunology. He is also past President of the American Academy of Allergy, Asthma and Immunology. He serves on the editorial board of the Journal of Clinical and Experimental Allergy. He is a member of the Advisory Council of the National Heart, Lung, and Blood Institute. Dr. Busse is the author of more than 150 scientific articles and more than 100 chapters, books and invited papers. He is one of the authors of Allergy: Principles and Practices, and, with Dr. Stephen Holgate, Asthma and Rhinitis. He has been a fellow of the AAAAI since 1973. Dr. Busse received his undergraduate and medical degrees at the University of Wisconsin Medical School.
Prof. Dave Singh
Professor Dave Singh is Professor of Clinical Pharmacology and Respiratory Medicine and leads a translational airway pharmacology group investigating inflammation in asthma and COPD. His interests span from basic pharmacological studies using primary cells concerning corticosteroid insensitivity and novel molecular targets, through to early phase PoC clinical trials.
Prof. Paul O’Byrne
Professor Paul O’Byrne is Professor of Medicine and Chair of the Department of Medicine at McMaster University. He is world renowned for his research on asthma that is the result of allergies. He has 400+ peer-reviewed papers in highly regarded journals. He is member of the Executive Committee of the Global Initiative for Asthma (GINA) and is Associate Editor of Chest, Thorax and International Archives of Allergy and Immunology.